Melissa V Rewolinski - 12 Jul 2023 Form 3 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ David C. Hastings as attorney-in-fact for Melissa V. Rewolinski
Issuer symbol
ABUS
Transactions as of
12 Jul 2023
Net transactions value
$0
Form type
3
Filing time
13 Jul 2023, 16:11:03 UTC
Previous filing
15 Sep 2022
Next filing
24 May 2024

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney